| Primary |
| Dyspepsia |
16.7% |
| Gastritis |
16.7% |
| Gastrooesophageal Reflux Disease |
16.7% |
| Hyperthyroidism |
16.7% |
| Osteoporosis |
16.7% |
| Tachycardia |
16.7% |
|
| Diarrhoea |
20.0% |
| Eye Haemorrhage |
20.0% |
| Pain In Extremity |
20.0% |
| Tinnitus |
20.0% |
| Yellow Skin |
20.0% |
|
| Secondary |
| Pain |
15.5% |
| Hypertension |
9.7% |
| Multiple Drug Overdose |
6.8% |
| Thrombosis Prophylaxis |
6.8% |
| Osteoporosis |
5.8% |
| Drug Use For Unknown Indication |
4.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.9% |
| Pruritus |
4.9% |
| Constipation |
3.9% |
| Diabetic Neuropathy |
3.9% |
| Nausea |
3.9% |
| Procedural Pain |
3.9% |
| Sedation |
3.9% |
| Skin Reaction |
3.9% |
| Urinary Tract Infection |
3.9% |
| Cerebral Infarction |
2.9% |
| Endocarditis |
2.9% |
| Prophylaxis |
2.9% |
| Toxoplasmosis |
2.9% |
| Anaemia |
1.9% |
|
| Stevens-johnson Syndrome |
22.2% |
| Intentional Overdose |
16.7% |
| Nausea |
16.7% |
| Medication Error |
5.6% |
| Pancreatitis |
5.6% |
| Sepsis |
5.6% |
| Sinus Bradycardia |
5.6% |
| Stomach Discomfort |
5.6% |
| Suicide Attempt |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| Weight Decreased |
5.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.1% |
| Hypertension |
17.1% |
| Drug Use For Unknown Indication |
15.4% |
| Pain |
4.7% |
| Rheumatoid Arthritis |
4.3% |
| Atrial Fibrillation |
2.9% |
| Prophylaxis |
2.3% |
| Renal Transplant |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Hodgkin's Disease |
2.1% |
| Depression |
2.0% |
| Gastritis |
1.9% |
| Osteoporosis |
1.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Diabetes Mellitus |
1.6% |
| Nausea |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Hypercholesterolaemia |
1.2% |
| Hyperuricaemia |
1.2% |
|
| Vomiting |
12.6% |
| Syncope |
10.5% |
| Thrombocytopenia |
8.4% |
| Pneumonia |
7.4% |
| Hyposmia |
5.3% |
| Renal Failure Acute |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Gamma-glutamyltransferase Increased |
4.2% |
| Gastrointestinal Haemorrhage |
4.2% |
| Pancreatitis |
4.2% |
| Weight Decreased |
4.2% |
| Death |
3.2% |
| Diabetes Mellitus Inadequate Control |
3.2% |
| Paraesthesia |
3.2% |
| Pleurisy |
3.2% |
| Prostate Cancer |
3.2% |
| Pulmonary Oedema |
3.2% |
| Rectal Haemorrhage |
3.2% |
| Renal Failure |
3.2% |
| Urinary Retention |
3.2% |
|
| Interacting |
| Renal Failure Chronic |
25.0% |
| Heart Transplant |
16.7% |
| Hypertension |
16.7% |
| Muscle Tightness |
16.7% |
| Dyslipidaemia |
8.3% |
| Ischaemic Heart Disease Prophylaxis |
8.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
8.3% |
|
| Upper Respiratory Tract Infection |
100.0% |
|
